Airbag-type Stretchable Electrode Array(ASEA) for Electrical Stimulation in Urinary Incontinence in Postmenopausal Women
Gynecology Department of Women's Hospital School of Medicine Zhejiang University
1 other identifier
interventional
58
1 country
1
Brief Summary
The prevalence of urinary incontinence increases after the menopause and affects between 38 % and 55 % of women aged over 60 years. Urinary incontinence has a profound impact on quality of life. Pelvic floor muscle training is the first-line management for urinary incontinence. Electrical stimulation is considered for improving contraction of pelvic floor muscles and aid motivation and adherence to therapy and commonly used in pelvic floor muscle training in clinic therapy. However, the stability and quality of the signals collected by existing stretchable electronics (two-channel hard electrode) are too poor especially when muscle movement is involved, making them inappropriate for aureate pelvic floor muscle training. Here, we propose a physiology-based design method for the stretchable electronics and a novel airbag-type stretchable electrode array (ASEA) device for pelvic floor muscle training. In this study, the investigators hypothesis that ASEA is effective in controlling UI. A randomized, open, and controlled study will be implemented. "participants with ASEA will be included and be prescribed. Two-channel hard electrode as electrical stimulation electrode will be used as positive control.The primary efficacy end points is the reduction of symptom scoring and improving of quality-of-life assessment, the frequency of UI at 12th week assessed with bladder diaries and pad testing, and the quality-of-life assessed with incontinence impact questionnaire short form (IIQ-7) and pelvic organ prolapsed-urinary incontinence sexual questionnaire-12(PISQ-12). The adverse event and medication compliance will be investigated. The aim of this study is to explore the efficacy, safety and therapy of ASEA as electrical stimulation electrode in management of UI. This study will provide new options of electrode for the electrical stimulation in management of UI, which will help improve precision therapy of UI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 22, 2022
CompletedFirst Posted
Study publicly available on registry
August 18, 2022
CompletedStudy Start
First participant enrolled
September 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedApril 27, 2023
April 1, 2023
2.1 years
February 22, 2022
April 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
The change of quality of life
Use a validated urinary incontinence-specific symptom and quality-of-life questionnaire as follows: Urinary incontinence impact questionnaire IIQ-7, Pelvic organ prolapse / urinary incontinence sexual function questionnaire PISQ-12, Each questionnaire the maximum score is 100 and the minimum score is 0, the higher the score, the worse quality of life.
Baseline score, Change from Baseline score at 12 weeks
The change of quantify urine loss
The change of urine loss measured by pad test. A pad weight gain≥ 2 g is positive. Mild: 2 g≤ weight gain \<5 g; Moderate: 5 g ≤ weight gain \< 10 g; Severe: 10 g ≤ weight gain \< 50 g; extremely severe Degree: weight gain≥ 50 g. The increasing of weight gain means UI aggravation, while the reduction of weight gain means effective.
Baseline weight gain, Change from Baseline weight gain at 12 weeks
Secondary Outcomes (1)
The change of symptom scoring
Baseline frequency of symptom scoring, Change from Baseline frequency of symptom scoring at 12 weeks
Study Arms (2)
group 1
EXPERIMENTALPropose a novel airbag-type stretchable electrode array (ASEA) device for training of the female pelvic floor muscle (PFM) for the treatment of UI
group 2
ACTIVE COMPARATORPropose a two-channel hard electrode device for training of the female pelvic floor muscle (PFM) for the treatment of UI
Interventions
Propose a novel airbag-type stretchable electrode array (ASEA) device for electrical stimulation for training of the female pelvic floor muscle (PFM) for the treatment of UI
Propose a two-channel hard electrode device for electrical stimulation for training of the female pelvic floor muscle (PFM) for the treatment of UI
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of UI
- Have a history of sex
- Menopause≥1 year
You may not qualify if:
- Acute reproductive organ inflammation
- With cardiac pacemakers
- Malignant tumors
- History of pelvic radiotherapy
- Pelvic floor surgery≤6 months
- Any disease or symptom that may affect the implementation of the study or the interpretation of the results
- Participate in other clinical trials at the same time
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Zhenwei Xielead
Study Sites (1)
Women's Hospital School of Medicine Zhejiang University
Hangzhou, Zhejiang, 310000, China
Related Publications (4)
Wu JM, Vaughan CP, Goode PS, Redden DT, Burgio KL, Richter HE, Markland AD. Prevalence and trends of symptomatic pelvic floor disorders in U.S. women. Obstet Gynecol. 2014 Jan;123(1):141-148. doi: 10.1097/AOG.0000000000000057.
PMID: 24463674BACKGROUNDZuchelo LTS, Bezerra IMP, Da Silva ATM, Gomes JM, Soares Junior JM, Chada Baracat E, de Abreu LC, Sorpreso ICE. Questionnaires to evaluate pelvic floor dysfunction in the postpartum period: a systematic review. Int J Womens Health. 2018 Aug 8;10:409-424. doi: 10.2147/IJWH.S164266. eCollection 2018.
PMID: 30123009BACKGROUNDTinelli A, Malvasi A, Rahimi S, Negro R, Vergara D, Martignago R, Pellegrino M, Cavallotti C. Age-related pelvic floor modifications and prolapse risk factors in postmenopausal women. Menopause. 2010 Jan-Feb;17(1):204-12. doi: 10.1097/gme.0b013e3181b0c2ae.
PMID: 19629013BACKGROUNDKoenig I, Luginbuehl H, Radlinger L. Reliability of pelvic floor muscle electromyography tested on healthy women and women with pelvic floor muscle dysfunction. Ann Phys Rehabil Med. 2017 Nov;60(6):382-386. doi: 10.1016/j.rehab.2017.04.002. Epub 2017 Jul 14.
PMID: 28716538BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Zhenwei Xie, MD
Zhejiang University
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- profressor
Study Record Dates
First Submitted
February 22, 2022
First Posted
August 18, 2022
Study Start
September 1, 2022
Primary Completion
September 30, 2024
Study Completion
December 31, 2024
Last Updated
April 27, 2023
Record last verified: 2023-04
Data Sharing
- IPD Sharing
- Will not share